Literature DB >> 21882348

Hydrophobic oxime ethers: a versatile class of pDNA and siRNA transfection lipids.

Souvik Biswas1, Ralph J Knipp, Laura E Gordon, Seshagiri R Nandula, Sven-Ulrik Gorr, Geoffrey J Clark, Michael H Nantz.   

Abstract

The manipulation of the cationic lipid structures to increase pan> class="Chemical">polynucleotide binding and delivery properties, while also minimizing associated cytotoxicity, has been a principal strategy for developing next-generation transfection agents. The polar (DNA binding) and hydrophobic domains of transfection lipids have been extensively studied; however, the linking domain comprising the substructure used to tether the polar and hydrophobic domains has attracted considerably less attention as an optimization variable. Here, we examine the use of an oxime ether as the linking domain. Hydrophobic oxime ethers were readily assembled via click chemistry by oximation of hydrophobic aldehydes using an aminooxy salt. A facile ligation reaction delivered the desired compounds with hydrophobic domain asymmetry. Using the MCF-7 breast cancer, H1792 lung cancer and PAR C10 salivary epithelial cell lines, our findings show that lipoplexes derived from oxime ether lipids transfect in the presence of serum at higher levels than commonly used liposome formulations, based on both luciferase and green fluorescent protein (GFP) assays. Given the biological compatibility of oxime ethers and their ease of formation, this functional group should find significant application as a linking domain in future designs of transfection vectors.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21882348      PMCID: PMC3442363          DOI: 10.1002/cmdc.201100259

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  39 in total

Review 1.  Gene therapy: the first decade.

Authors:  A Mountain
Journal:  Trends Biotechnol       Date:  2000-03       Impact factor: 19.536

Review 2.  Nonviral gene therapy: promises and challenges.

Authors:  S Li; L Huang
Journal:  Gene Ther       Date:  2000-01       Impact factor: 5.250

3.  Synthesis of oxime-linked mucin mimics containing the tumor-related T(N) and sialyl T(N) antigens.

Authors:  L A Marcaurelle; Y Shin; S Goon; C R Bertozzi
Journal:  Org Lett       Date:  2001-11-15       Impact factor: 6.005

Review 4.  Viral gene therapy strategies: from basic science to clinical application.

Authors:  Lawrence S Young; Peter F Searle; David Onion; Vivien Mautner
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

5.  Formation and intracellular trafficking of lipoplexes and polyplexes.

Authors:  Abdelatif Elouahabi; Jean-Marie Ruysschaert
Journal:  Mol Ther       Date:  2005-03       Impact factor: 11.454

6.  Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles.

Authors:  R Leventis; J R Silvius
Journal:  Biochim Biophys Acta       Date:  1990-03-30

7.  Aminooxy pluronics: synthesis and preparation of glycosaminoglycan adducts.

Authors:  Joanna Gajewiak; Shenshen Cai; Xiao Zheng Shu; Glenn D Prestwich
Journal:  Biomacromolecules       Date:  2006-06       Impact factor: 6.988

Review 8.  Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.

Authors:  D P Figgitt; K J McClellan
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 9.  Progress in cationic lipid-mediated gene transfection: a series of bio-inspired lipids as an example.

Authors:  Tristan Montier; Thierry Benvegnu; Paul-Alain Jaffrès; Jean-Jacques Yaouanc; Pierre Lehn
Journal:  Curr Gene Ther       Date:  2008-10       Impact factor: 4.391

10.  Synthesis and formulation of neoglycolipids for the functionalization of liposomes and lipoplexes.

Authors:  Eric Perouzel; Michael R Jorgensen; Michael Keller; Andrew D Miller
Journal:  Bioconjug Chem       Date:  2003 Sep-Oct       Impact factor: 4.774

View more
  6 in total

Review 1.  siRNA delivery to the lung: what's new?

Authors:  Olivia M Merkel; Israel Rubinstein; Thomas Kissel
Journal:  Adv Drug Deliv Rev       Date:  2014-06-05       Impact factor: 15.470

2.  Oxime ether lipids containing hydroxylated head groups are more superior siRNA delivery agents than their nonhydroxylated counterparts.

Authors:  Kshitij Gupta; Stephanie J Mattingly; Ralph J Knipp; Kirill A Afonin; Mathias Viard; Joseph T Bergman; Marissa Stepler; Michael H Nantz; Anu Puri; Bruce A Shapiro
Journal:  Nanomedicine (Lond)       Date:  2015-06-24       Impact factor: 5.307

3.  Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems.

Authors:  Susanne R Youngren-Ortiz; Nishant S Gandhi; Laura España-Serrano; Mahavir B Chougule
Journal:  Kona       Date:  2016-04-30       Impact factor: 2.897

4.  Stealth oxime ether lipid vesicles promote delivery of functional DsiRNA in human lung cancer A549 tumor bearing mouse xenografts.

Authors:  Anu Puri; Faisal Ibrahim; André O'Reilly Beringhs; Camryn Isemann; Paul Zakrevsky; Abigail Whittenburg; Derek Hargrove; Tapan Kanai; Rebecca S Dillard; Natalia de Val; Michael H Nantz; Xiuling Lu; Bruce A Shapiro
Journal:  Nanomedicine       Date:  2022-06-04       Impact factor: 6.096

Review 5.  Cellular Delivery of RNA Nanoparticles.

Authors:  Lorena Parlea; Anu Puri; Wojciech Kasprzak; Eckart Bindewald; Paul Zakrevsky; Emily Satterwhite; Kenya Joseph; Kirill A Afonin; Bruce A Shapiro
Journal:  ACS Comb Sci       Date:  2016-08-26       Impact factor: 3.784

Review 6.  Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine-Specific Cancer Targeting with Undetectable Toxicity.

Authors:  Daniel W Binzel; Xin Li; Nicolas Burns; Eshan Khan; Wen-Jui Lee; Li-Ching Chen; Satheesh Ellipilli; Wayne Miles; Yuan Soon Ho; Peixuan Guo
Journal:  Chem Rev       Date:  2021-05-26       Impact factor: 72.087

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.